Cargando…
Xanthine–Dopamine Hybrid Molecules as Multitarget Drugs with Potential for the Treatment of Neurodegenerative Diseases
Multitarget drugs based on a hybrid dopamine–xanthine core were designed as potential drug candidates for the treatment of neurodegenerative diseases. Monoamine oxidase B (MAO-B) inhibitors with significant ancillary A(2A) adenosine receptor (A(2A)AR) antagonistic properties were further developed t...
Autores principales: | Załuski, Michał, Karcz, Tadeusz, Drabczyńska, Anna, Vielmuth, Christin, Olejarz-Maciej, Agnieszka, Głuch-Lutwin, Monika, Mordyl, Barbara, Siwek, Agata, Satała, Grzegorz, Müller, Christa E., Kieć-Kononowicz, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377586/ https://www.ncbi.nlm.nih.gov/pubmed/37509114 http://dx.doi.org/10.3390/biom13071079 |
Ejemplares similares
-
Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione - a novel anticonvulsant drug candidate
por: Kaproń, Barbara, et al.
Publicado: (2017) -
Dual Molecules
Targeting 5-HT(6) and
GABA-A Receptors as a New Approach to Combat Depression Associated
with Neuroinflammation
por: Marcinkowska, Monika, et al.
Publicado: (2023) -
Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones
por: Drabczyńska, Anna, et al.
Publicado: (2013) -
Modulation of the MOP Receptor (μ Opioid Receptor) by Imidazo[1,2-a]imidazole-5,6-Diones: In Search of the Elucidation of the Mechanism of Action
por: Straszak, Dominik, et al.
Publicado: (2022) -
Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats
por: Sadek, Bassem, et al.
Publicado: (2016)